Nom du produit:Boc-Gly-Gly-Phe-Gly-OH

IUPAC Name:2-[(2S)-2-[2-(2-{[(tert-butoxy)carbonyl]amino}acetamido)acetamido]-3-phenylpropanamido]acetic acid

CAS:187794-49-6
Formule moléculaire:C20H28N4O7
Pureté:95%+
Numéro de catalogue:CM339113
Poids moléculaire:436.47

Unité d'emballage Stock disponible Prix($) Quantité
CM339113-1g in stock ʼnĽȎ
CM339113-5g in stock ȎʼnƄ
CM339113-10g in stock ƄNJƄ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:187794-49-6
Formule moléculaire:C20H28N4O7
Point de fusion:-
Code SMILES:CC(C)(C)OC(=O)NCC(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O
Densité:
Numéro de catalogue:CM339113
Poids moléculaire:436.47
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

ADC-Linkers
The ADC linker is one of the three main components of antibody drug conjugates (ADCs), linking the antibody to the effective drug (payload) through chemical bonds. ADC linkers play a key role in determining the overall success of antibody drug conjugates. One of the major challenges in developing safe and effective ADC drugs is to assemble an ideal chemical linker between the cytotoxic payload and the mAb. Well-designed ADC linkers can help the selective delivery of antibodies at the tumor site and the accurate release of cytotoxic drugs.
Cleavable linkers
Cleavable linkers rely on the inherent properties of a cell’s cytoplasmic compartments for selective release of the cytotoxic drug.
Peptide linkers
Peptide linkers belong to protease-sensitivity linkers (also called enzymatically cleavable linkers) that have gained significant attention in ADC development due to their superior plasma stability and controled payload release mechanism.

Related Products